Patient characteristics
hypertension
PRIMARY TUMOR, LIVER METASTASES, HYPERTENSION, TYPE 2 DIABETES
Between November 6, 2020, and January 19, 2022, a total of 29 patients were enrolled in the study, and the cutoff date for OS was October 30, 2022. The median age of the patients was 69 years (range: 65–77), and 16 (44.8%) were male. Only 13.8% (4/29) of patients had an ECOG of 0. The primary tumor was located in the right colon in three cases (10.3%), in the left colon in 10 cases (34.5%), and in the rectum in 16 cases (55.2%). 79.3% (23/29) of patients underwent surgical resection of the primary tumor. Liver metastases (22/29) were the most common metastatic site. All patients received two or more previous chemotherapeutic regimens (median 2). Controllable hypertension (5/29; 17.2%) and type 2 diabetes (5/29; 17.2%) were the most common comorbidities. Most patients (27/29) had also received targeted therapy, with 82.8% (24/29) receiving bevacizumab and 10.3% (3/29) receiving anti‐EGFR monoclonal antibody. GA and G8 were performed for all patients at baseline. Detailed clinical characteristics, GA, and G8 information of the patients can be found in Table Baseline clinical characteristics and geriatric assessment.